pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Study finds training bystanders and responders does not boost survival after sudden cardiac arrest

Nov 8, 2026·read at STAT ↗Negative

Sudden cardiac arrest kills about 350,000 people in the United States each year, and only one in ten victims survive. Survival depends heavily on rapid CPR and defibrillation by nearby bystanders or emergency crews, with chances dropping roughly 10% for each minute without intervention.

A randomized controlled trial presented at the American Heart Association scientific sessions and published in the New England Journal of Medicine tested whether advanced training of 911 dispatchers, first responders and potential bystanders would improve outcomes. The study found no statistically significant increase in survival rates compared with standard practice.

The investigators cautioned that the findings do not rule out benefits from longer-term education programs or mandatory CPR training, such as those implemented in Denmark. They suggest further research to identify more effective community‑based strategies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Survival after sudden cardiac arrest didn’t improve despite training bystanders, emergency responders”

read at STAT ↗
1,232 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2NOVARTISNOVORHYTHM
topics
Cardiology13Endocrinology & Metabolism2Hematology2Type 2 Diabetes

related stories

  • 1d agoLowering blood pressure after stroke or with diabetes poses challenges, in research and practiceSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Alethio attains $90M series A for rare blood cancer drugsFierce Biotech
  • 2d agoVoyager, C4 cut workforcesBioSpace
  • Oct 14Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugsBioSpace